(Q40408831)

20 September 2017

1 reference

title

Combined modality treatment for stage III non-small cell lung cancer (English)

1 reference

20 September 2017

Bonomi P

1

1 reference

20 September 2017

1 June 1995

1 reference

20 September 2017

1 reference

20 September 2017

12 Suppl 2

1 reference

20 September 2017

S41-52

1 reference

20 September 2017

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

A new international staging system for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Stage IIIA category of non-small-cell lung cancer: a new proposal.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

The role of surgery in N2 lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Radiotherapy in the management of locally advanced lung cancer of all cell types: final report of randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Lack of apparent difference in outcome between clinically staged IIIA and IIIB non-small-cell lung cancer treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Comparison of the Radiation Therapy Oncology Group and American Joint Committee on Cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy. A report of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. A randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Inoperable non-small cell lung cancer: radiation with or without chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Induction chemotherapy for locally advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980005-4

7 January 2021

10.1016/S0169-5002(10)80005-4

Identifiers

DOI

0 references

PubMed ID

7551949

1 reference

PubMed ID

7551949